Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

February 25, 2021

Latest advances in hydrogel-based drug delivery systems for optimization of metabolic syndrome treatment.

Current Medicinal Chemistry
Diego AraunaEsteban Durán-Lara
February 25, 2021
Open Access

Skin AGEs and diabetic neuropathy.

BMC Endocrine Disorders
Stella PapachristouNikolaos Papanas
February 25, 2021
Open Access

Cheap and simple, could it get even cooler? Mild hypothermia and COVID-19.

Journal of Critical Care
Raul Dos Reis Ururahy, Marcelo Park
February 25, 2021
Open Access

Systematic Development of Structured Semi-interactive Stroke Prevention Package for Secondary Stroke Prevention.

Annals of Indian Academy of Neurology
Mahesh Pundlik KateJeyaraj Durai Pandian
February 25, 2021
Open Access

Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era.

European Journal of Preventive Cardiology
Marco AmbrosettiCarlo Vigorito
February 25, 2021
Open Access

A metabolomic approach to identify the link between sports activity and atheroprotection.

European Journal of Preventive Cardiology
Frank BeutnerUta Ceglarek
February 25, 2021
Open Access

Promotion of Arterial Stiffness by Childhood Cancer and Its Characteristics in Adult Long-Term Survivors.

Journal of the American Heart Association
Natalie ArnoldPhilipp S Wild
February 25, 2021

[MiR-600 suppresses HeLa cell proliferation by inhibiting hypoxia-inducible factor-1α signaling pathway].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
X ZhouJ Wang
February 25, 2021

Bacillary Layer Detachment Due to Macular Neovascularization.

Jesse J JungQuan V Hoang
February 25, 2021

Cannabinoid Receptor 1 and 2 Signalling Pathways Involved in Sepsis.

Mariane C G Leite-AvalcaChristian Lehmann
February 25, 2021

In-silico based identification of phytochemicals from Houttuynia cordata Thunb. as potential inhibitors for overexpressed HER2 and VEGFR2 cancer genes.

Journal of Biomolecular Structure & Dynamics
Sanjib Kumar DasPallabi Kalita Hui
February 25, 2021

Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.

Cardiovascular Toxicology
Hsiang-Jung TsengMu-Hong Chen
February 25, 2021

Evolution of medication consumption in a working environment in France: results of the 4 waves of the « Drugs and Work » study (1986-2016).

Pharmacoepidemiology and Drug Safety
Herin FabriceLapeyre-Mestre Maryse
February 25, 2021

[SGLT2 inhibitors in diabetic and non-diabetic nephropathies].

Revue médicale suisse
Marc ScheenSophie De Seigneux
February 25, 2021

Comorbidity and Lymphatic Disease: The Lymphatic Continuum Re-Examined.

Lymphatic Research and Biology
Stanley G Rockson

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2021 Meta ULC. All rights reserved